Zealand Pharma A/S (NASDAQ:ZLDPF) has earned an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.

Zacks has also given Zealand Pharma A/S an industry rank of 106 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research raised shares of Zealand Pharma A/S from a “sell” rating to a “hold” rating in a research note on Tuesday, September 26th.

Shares of Zealand Pharma A/S (NASDAQ ZLDPF) traded up 1.36% on Monday, reaching $18.70. The company’s 50-day moving average price is $18.60 and its 200 day moving average price is $18.08. The stock’s market capitalization is $478.91 million. Zealand Pharma A/S has a one year low of $14.95 and a one year high of $19.51.

COPYRIGHT VIOLATION WARNING: This piece was reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/10/23/zacks-zealand-pharma-as-zldpf-given-average-rating-of-strong-buy-by-brokerages.html.

Get a free copy of the Zacks research report on Zealand Pharma A/S (ZLDPF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Zealand Pharma A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zealand Pharma A/S and related companies with MarketBeat.com's FREE daily email newsletter.